Nakanishi-Koakutsu, Misato http://orcid.org/0000-0001-6205-6024
Miki, Kenji http://orcid.org/0000-0001-7901-6133
Naka, Yuki
Sasaki, Masako
Wakimizu, Takayuki
Napier, Stephanie C.
Okubo, Chikako http://orcid.org/0000-0001-5562-410X
Narita, Megumi http://orcid.org/0000-0002-8198-4042
Nishikawa, Misato
Hata, Reo
Chonabayashi, Kazuhisa
Hotta, Akitsu http://orcid.org/0000-0002-2619-7441
Imahashi, Kenichi
Nishimoto, Tomoyuki
Yoshida, Yoshinori http://orcid.org/0000-0001-5511-9090
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP17H04176, JP 21H02912, JP19K16041, JP18K15120, JP18KK0461)
Fondation Leducq (18CVD05)
Japan Agency for Medical Research and Development (JP20bm0104001, JP21bm0204003, JP21bm0804008, JP21bm0804022, JP23bm1423011, JP23bm132300, JP21mk0101189, JP22mk0101241, JP22ym0126091, JP21bk0104095)
Article History
Received: 3 September 2022
Accepted: 11 January 2024
First Online: 28 February 2024
Competing interests
: The authors declare the following competing interests: Y.Y. is a scientific advisor of Orizuru Therapeutics, Inc. and received research funding from Takeda Pharmaceutical Company, Ltd. and Altos Labs, Inc. S.C.N. and K.I. are employees of Takeda Pharmaceutical Company, Ltd. T.N. is an employee of Orizuru Therapeutics, Inc. M.N.K, K.M., and Y.Y. are the inventors of the patent application (WO2021/033699 and 2022/125789). The other authors declare no competing interests.